Zenapro™ Hybrid Hernia Repair Device
DeviceDevice will be placed during open or laparoscopic hernia repair.
NCT Number: NCT01784822
The objective this study is to collect post-market data on the performance of the Zenapro™ Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Duke University, Durham, North Carolina, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Device will be placed during open or laparoscopic hernia repair.
Time frame: 12 months
Cook Group Incorporated
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01962480
Hernia, Hernia, Abdominal
Hvidovre, Denmark
View Trial DetailsNCT01183325
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hernia
Bonheiden, Belgium
View Trial DetailsNCT01673568
Hernia, Hernia, Abdominal
Hvidovre, CPH, Denmark
View Trial DetailsNCT07451483
Abdominal Neoplasms, Adenocarcinoma
Anderlecht, Brussels Capital, Belgium
View Trial Details